1. Home
  2. WEAV vs FHTX Comparison

WEAV vs FHTX Comparison

Compare WEAV & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weave Communications Inc.

WEAV

Weave Communications Inc.

HOLD

Current Price

$7.28

Market Cap

413.7M

Sector

Technology

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$6.75

Market Cap

360.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEAV
FHTX
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
413.7M
360.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
WEAV
FHTX
Price
$7.28
$6.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$11.00
$11.50
AVG Volume (30 Days)
1.2M
198.6K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
7.50
25.32
EPS
N/A
N/A
Revenue
$239,024,000.00
$30,909,000.00
Revenue This Year
$17.20
$8.89
Revenue Next Year
$13.74
$20.13
P/E Ratio
N/A
N/A
Revenue Growth
16.99
36.75
52 Week Low
$4.24
$3.27
52 Week High
$8.11
$6.95

Technical Indicators

Market Signals
Indicator
WEAV
FHTX
Relative Strength Index (RSI) 63.11 69.79
Support Level $6.71 $4.43
Resistance Level $7.35 N/A
Average True Range (ATR) 0.32 0.45
MACD 0.01 0.14
Stochastic Oscillator 99.06 95.19

Price Performance

Historical Comparison
WEAV
FHTX

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and generates revenue mainly from subscriptions.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: